Literature DB >> 3917979

Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide.

C Moreno, M R Lifely, J Esdaile.   

Abstract

A methodology for preparing outer membrane proteins (type specific) complexed to group B polysaccharide of Neisseria meningitidis is described. These complexes, low in nucleic acid and lipopolysaccharide content, were immunogenic in mice with induction of humoral antigroup B and antiprotein responses. Immunized mice were also protected against challenge with N. meningitidis group B strains of the same or a different type from that used for vaccination. Both immunity and protection were enhanced when the mice received a secondary immunization with the protein-polysaccharide complex. Additional data have shown the capacity of purified B polysaccharide to induce immunological memory, even though it is incapable of inducing a humoral response when given alone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917979      PMCID: PMC263203          DOI: 10.1128/iai.47.2.527-533.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

2.  Effect of adjuvants on the antibody response to a hapten on a thymus-independent carrier.

Authors:  P Del Guercio
Journal:  Nat New Biol       Date:  1972-08-16

3.  Immunologic response of man to group B meningococcal polysaccharide vaccines.

Authors:  F A Wyle; M S Artenstein; B L Brandt; E C Tramont; D L Kasper; P L Altieri; S L Berman; J P Lowenthal
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

4.  The immunological responses observed in field studies in Africa with group A meningococcal vaccines.

Authors:  E C Gotschlich; M Rey; J Etienne; W R Sanborn; R Triau; B Cvjetanović
Journal:  Prog Immunobiol Stand       Date:  1971

5.  Enhanced stability of meningococcal polysaccharide vaccines by using lactose as a menstruum for lyophilization.

Authors:  R H Tiesjema; E C Beuvery; B J te Pas
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

6.  A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody.

Authors:  B L Brandt; F A Wyle; M S Artenstein
Journal:  J Immunol       Date:  1972-04       Impact factor: 5.422

7.  B cell tolerance induced by polymeric antigens. I. Comparison of the dose and epitope density requirements for inactivation of primed and unprimed B cells in vivo.

Authors:  G G Klaus; J H Humphrey
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

8.  T and B cell in hapten-specific carrier-determined tolerance.

Authors:  Y Borel; C L Reinisch; S F Schlossman
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  Protection against group B meningococcal disease. II. Infection and resulting immunity in a guinea pig model.

Authors:  C E Frasch; J D Robbins
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  15 in total

1.  Specificity of the immune response to the group B polysaccharide of Neisseria meningitidis.

Authors:  M R Lifely; J Esdaile
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

2.  Thymic-dependence and immune memory in mice vaccinated with meningococcal polysaccharide group B complexed to outer membrane protein.

Authors:  C Moreno; J Esdaile; M R Lifely
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

3.  A thymus-independent (type 1) phosphorylcholine antigen isolated from Trichinella spiralis protects mice against pneumococcal infection.

Authors:  P L Lim; W F Choy
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

Review 4.  Vaccines for prevention of meningococcal disease.

Authors:  C E Frasch
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination.

Authors:  R E Mandrell; W D Zollinger
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

6.  Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis.

Authors:  L Ferron; C M Ferreiros; M T Criado; M Pintor
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

7.  Dynamics of the murine humoral immune response to Neisseria meningitis group B capsular polysaccharide.

Authors:  J Colino; I Outschoorn
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.

Authors:  F H Azmi; A H Lucas; H V Raff; D M Granoff
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.

Authors:  N Moayeri; C M Collins; P O'Hanley
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  Effect of aluminum ions on chemical and immunological properties of meningococcal group B polysaccharide.

Authors:  C Moreno; M R Lifely; J Esdaile
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.